Digital therapeutics startup Dthera Sciences was sunk by Alzheimer ' s drug failures, CMS reimbursement limitations

Former CEO Ed Cox tells the story of Dthera Sciences and outlines how the digital therapeutics landscape has shifted since his company ' s heyday.
Source: mobihealthnews - Category: Information Technology Tags: Digital Health, Finance, Reimbusement, Investing, Life Sciences, Pharma, Technology, Business, Care Source Type: news